| Recruiting | ENAVOgliflozin Outcome Trial in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacem Aortic Valve Stenosis, Heart Failure | Phase 4 | 2024-12-18 |
| Recruiting | Diabetes-Centered Evaluation of Revascularization Strategy of Functional and Imaging-CombiNEd State-of-the-Art Coronary Artery Stenosis | N/A | 2024-06-14 |
| Completed | The Sentinel Registry Aortic Valve Disease, Transcatheter Aortic Valve Implantation, Transcatheter Aortic Valve Replacement | — | 2022-05-18 |
| Recruiting | Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at Coronary Artery Disease, Percutaneous Coronary Intervention, Acute Coronary Syndrome | Phase 4 | 2021-05-12 |
| Completed | Transcatheter Mitral Valvuloplasty Pilot Study Mitral Valve Insufficiency, Mitral Regurgitation, Mitral Valve Regurgitation | — | 2020-10-20 |
| Recruiting | Evaluation of Effectiveness and Safety of Ultimaster™ Tansei™ Stent in Routine Clinical Practice Coronary Artery Disease | — | 2020-09-17 |
| Recruiting | Transpacific TAVR Registry Heart Valve Diseases, Aortic Valve Insufficiency | — | 2019-06-15 |
| Completed | TAILored Versus COnventional AntithRombotic StratEgy IntenDed for Complex HIgh-Risk PCI Coronary Stenoses | Phase 4 | 2019-02-12 |
| Completed | Anticoagulant Versus Dual Antiplatelet Therapy for Preventing Leaflet Thrombosis and Cerebral Embolization Aft Aortic Valve Stenosis | Phase 4 | 2018-03-15 |
| Withdrawn | IRIS-Firehawk® Cohort in the IRIS-DES Registry Coronary Stenosis, Coronary Disease | — | 2018-03-01 |
| Completed | IRIS Ultimaster Cohort in the IRIS-DES Registry Coronary Artery Disease | — | 2016-07-20 |
| Terminated | Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents for Diffuse Long Coronary Percutaneous Transluminal Coronary Angioplasty | Phase 4 | 2016-07-01 |
| Terminated | IRIS-BVS AMI Registry Arterial Occlusive Diseases, Cardiovascular Diseases, Coronary Artery Disease | — | 2016-06-01 |
| Terminated | Evaluation of Effectiveness and Safety of Bioresorbable Vascular Scaffold in Routine Clinical Practice Arterial Occlusive Diseases, Cardiovascular Diseases, Coronary Artery Disease | — | 2016-02-26 |